Seema Kantak

Seema Kantak

Company: Exelixis

Job title: Vice President


Target Expression & Warhead: The Driving Forces of ADC Activity 2:30 pm

How much target expression is needed for ADC activity? Do we know the correlation between level of expression and payload type? Could testing ADC activity in 3D tumor organoid systems give better clinical translation in terms of ADC activity as related to target expression and payload?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.